Mexico’s foreign minister Marcelo Ebrard said on Friday that CureVac and Novavax have begun their phase III clinical trials in Mexico for a COVID-19 vaccine.
China’s CanSino Biologics Inc is due to present the results of its phase III trial, Ebrard also said.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.